Are you feeling overwhelmed or worried about being left behind by AI? If so, you’re not alone. Here’s a key point: AI isn’t just another
Understanding the needs and problems emerging from quantitative data analysis is crucial for driving objective, realistic and purposeful innovations across societal, private, government, or any
If you are a pet lover like me or a researcher involved in building innovative pet solutions using AI/ML, this post is for you. The
GenAI can perform various tasks for us, but to achieve the best results and build innovative GenAI-based models incorporating proprietary data and applications, we must
Adopting Agile methodologies can often be challenging, especially in corporate environments where dependencies on non-Agile team members and rigid organizational structures can dilute Agile’s core
In the age of digital transformation, the wellness industry is ripe for innovation. The Wellness-as-a-Service (WaaS) concept is emerging as a transformative approach, blending technology,
Being a proponent of innovation and having acquired experience by working in business functions ranging from Business Operations, R&D, HR, Finance, Legal, Compliance, Manufacturing, Product
Data mesh is an innovative approach to managing and accessing data across large organizations, designed to address the complexities and inefficiencies of handling vast amounts
In my professional writing, a few of my articles originate from fleeting thoughts, which are carefully recorded and later elaborated in my blog. This article’s
Designing a system to ensure that AI technology behaves ethically, follows the rules, and acts responsibly when handling data is complex. This system should include
How to Cultivate a Culture of Data Products and Monetization
Today, organizations across diverse sectors are accumulating vast quantities of data at an unparalleled scale. As aptly expressed, ‘data is the new oil’ and ‘data
The future of Pharma R&D is replete with creativity and innovation through digital transformation
In the ever-evolving world of healthcare, the pharmaceutical industry continually seeks to make strides in research and development (R&D) — a task extraordinarily fragile, costly,